These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 34648589)

  • 1. Adolescent girls and young women's PrEP-user journey during an implementation science study in South Africa and Kenya.
    Rousseau E; Katz AWK; O'Rourke S; Bekker LG; Delany-Moretlwe S; Bukusi E; Travill D; Omollo V; Morton JF; O'Malley G; Haberer JE; Heffron R; Johnson R; Celum C; Baeten JM; van der Straten A
    PLoS One; 2021; 16(10):e0258542. PubMed ID: 34648589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring adolescent girls and young women's PrEP-user profiles: qualitative insights into differentiated PrEP delivery platform selection and engagement in Cape Town, South Africa.
    Rousseau E; Sikkema KJ; Julies RF; Mazer K; O'Malley G; Heffron R; Morton JF; Johnson R; Celum C; Baeten JM; Bekker LG
    J Int AIDS Soc; 2024 May; 27(5):e26254. PubMed ID: 38695101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol.
    Medina-Marino A; Bezuidenhout D; Hosek S; Barnabas RV; Atujuna M; Bezuidenhout C; Ngwepe P; Peters RPH; Little F; Celum CL; Daniels J; Bekker LG
    Trials; 2021 Jul; 22(1):489. PubMed ID: 34311754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors that influence adolescent girls and young women's re-initiation or complete discontinuation from daily oral PrEP use: a qualitative study from Eastern Cape Province, South Africa.
    de Vos L; Mudzingwa EK; Fynn L; Atujuna M; Mugore M; Gandhi M; Celum C; Hosek S; Bekker LG; Daniels J; Medina-Marino A
    J Int AIDS Soc; 2023 Sep; 26(9):e26175. PubMed ID: 37758649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study.
    Velloza J; Khoza N; Scorgie F; Chitukuta M; Mutero P; Mutiti K; Mangxilana N; Nobula L; Bulterys MA; Atujuna M; Hosek S; Heffron R; Bekker LG; Mgodi N; Chirenje M; Celum C; Delany-Moretlwe S;
    J Int AIDS Soc; 2020 Mar; 23(3):e25463. PubMed ID: 32144874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya.
    Mugwanya KK; Pintye J; Kinuthia J; Abuna F; Lagat H; Begnel ER; Dettinger JC; John-Stewart G; Baeten JM;
    PLoS Med; 2019 Sep; 16(9):e1002885. PubMed ID: 31479452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery.
    Celum CL; Delany-Moretlwe S; Baeten JM; van der Straten A; Hosek S; Bukusi EA; McConnell M; Barnabas RV; Bekker LG
    J Int AIDS Soc; 2019 Jul; 22 Suppl 4(Suppl Suppl 4):e25298. PubMed ID: 31328444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project.
    Celum CL; Bukusi EA; Bekker LG; Delany-Moretlwe S; Kidoguchi L; Omollo V; Rousseau E; Travill D; Morton JF; Mogaka F; O'Malley G; Barnabee G; van der Straten A; Donnell D; Parikh UM; Kudrick L; Anderson PL; Haberer JE; Wu L; Heffron R; Johnson R; Morrison S; Baeten JM;
    J Int AIDS Soc; 2022 Jul; 25(7):e25962. PubMed ID: 35822945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A community-based mobile clinic model delivering PrEP for HIV prevention to adolescent girls and young women in Cape Town, South Africa.
    Rousseau E; Bekker LG; Julies RF; Celum C; Morton J; Johnson R; Baeten JM; O'Malley G
    BMC Health Serv Res; 2021 Aug; 21(1):888. PubMed ID: 34454505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experiences of oral pre-exposure prophylaxis (PrEP) use disclosure among South African adolescent girls and young women and its perceived impact on adherence.
    Giovenco D; Gill K; Fynn L; Duyver M; O'Rourke S; van der Straten A; Morton JF; Celum CL; Bekker LG
    PLoS One; 2021; 16(3):e0248307. PubMed ID: 33667264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Awareness, Yet Low Uptake, of Pre-Exposure Prophylaxis Among Adolescent Girls and Young Women Within Family Planning Clinics in Kenya.
    Sila J; Larsen AM; Kinuthia J; Owiti G; Abuna F; Kohler PK; John-Stewart G; Pintye J
    AIDS Patient Care STDS; 2020 Aug; 34(8):336-343. PubMed ID: 32757980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stigma in the health clinic and implications for PrEP access and use by adolescent girls and young women: conflicting perspectives in South Africa.
    Nyblade L; Ndirangu JW; Speizer IS; Browne FA; Bonner CP; Minnis A; Kline TL; Ahmed K; Howard BN; Cox EN; Rinderle A; Wechsberg WM
    BMC Public Health; 2022 Oct; 22(1):1916. PubMed ID: 36242000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study.
    Haribhai S; Khadka N; Mvududu R; Mashele N; Bekker LG; Gorbach P; Coates TJ; Myer L; Joseph Davey DL
    Int J STD AIDS; 2023 Jul; 34(8):548-556. PubMed ID: 36947792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family influences on oral PrEP use among adolescent girls and young women in Kenya and South Africa.
    Ndimande-Khoza MN; Katz AWK; Moretlwe-Delany S; Travill D; Rousseau E; Omollo V; Morton J; Johnson R; Bekker LG; Bukusi EA; Baeten J; Celum C; van der Straten A; Roberts ST
    PLoS One; 2023; 18(11):e0292529. PubMed ID: 37963171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Stigma on Family Planning and HIV Pre-exposure Prophylaxis Decisions of Young Women Accessing Post-Abortion Care in Kenya.
    Zia Y; Etyang L; Mwangi M; Njiru R; Mogaka F; June L; Njeru I; Makoyo J; Kimani S; Ngure K; Wanyama I; Bukusi E; Nyerere B; Nyamwaro C; Mugo N; Heffron R;
    AIDS Behav; 2024 Jun; 28(6):1834-1844. PubMed ID: 38451448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative Analysis Using Social Maps to Explore Young Women's Experiences With Social Support of their Oral PrEP Use in Kenya and South Africa.
    Katz AWK; Roberts S; Rousseau E; Khoza MN; Mogaka F; Bukusi E; Delany-Moretlwe S; Bekker LG; Morton JF; Johnson R; Baeten JM; Celum C; van der Straten A
    J Assoc Nurses AIDS Care; 2023 Jan-Feb 01; 34(1):45-57. PubMed ID: 36170124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
    Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR
    BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Youth-friendly services was the magic: Experiences of adolescent girls and young women in the community PrEP study, South Africa.
    Mudzingwa EK; de Vos L; Fynn L; Atujuna M; Katz IT; Hosek S; Celum C; Daniels J; Bekker LG; Medina-Marino A
    Glob Public Health; 2024 Jan; 19(1):2349918. PubMed ID: 38752416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining concordance of sexual-related factors and PrEP eligibility with HIV risk perception among adolescent girls and young women: cross-sectional insights from DREAMS sites in Kenya, Malawi, and Zambia.
    Heck CJ; Reed DM; Okal J; Chipeta E; Mbizvo M; Mathur S
    BMC Public Health; 2024 Oct; 24(1):2793. PubMed ID: 39395932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A decision support tool has similar high PrEP uptake and increases early PrEP persistence in adolescent girls and young women in South Africa: results from a randomized controlled trial.
    Celum C; Seidman D; Travill D; Dehlendorf C; Gumede S; Zewdie K; Wilson W; Morton JF; Baeten JM; Donnell D; Delany-Moretlwe S
    J Int AIDS Soc; 2023 Aug; 26(8):e26154. PubMed ID: 37634942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.